|
楼主 |
发表于 2013-8-9 05:41 PM
|
显示全部楼层
本帖最后由 wsjboy 于 2013-8-13 01:45 PM 编辑
ACT, heal,actavis,drugs-genrc, in sp500_set ACT yahoo finviz google fool
alpha 75.50,beta 0.36,a_vol 1646, debt 1.8,insi 0.9 7.21,inst 91.3 7.64,
=================
Actavis, Inc., an integrated specialty pharmaceutical company, engages in developing, manufacturing, marketing, selling, and distributing generic, branded generic, brand, biosimilar, and over-the-counter pharmaceutical products worldwide. The company offers its products for various therapeutic categories, such as cardiovascular, dermatology, urology, womenÂ’s health, oncology, pregnancy prevention, hormones and synthetic substitutes, anti-infective agents, central nervous system, pain management, depression, hypertension, attention-deficit/hyperactivity disorder, and smoking cessation. It operates through three segments: Actavis Pharma, Actavis Specialty Brands, and Anda Distribution. The Actavis Pharma segment develops, manufactures, and sells generic pharmaceutical products, as well as distributes generic versions of third partiesÂ’ brand products. This segment offers various dosage forms, such as oral solids, semi-solids, liquids, gels, transdermals, injectables, inhalation, and oral transmucosals. The Actavis Specialty Brands segment promotes and co-promotes Rapaflo, Gelnique, Crinone, Trelstar, Generess Fe, Androderm, Kadian, Crinone, AndroGel, INFeD, and sodium ferric gluconate branded products; and markets its products through sales professionals, as well as sells various non-promoted products. The Anda Distribution segment distributes generic and selected brand pharmaceutical products, vaccines, injectables, and over-the-counter medicines to independent pharmacies, alternate care providers, pharmacy chains, and physiciansÂ’ offices. Actavis, Inc., sells its generic and brand pharmaceutical products primarily to drug wholesalers, retailers, and distributors; hospitals, clinics, mail order, and government agencies; and managed healthcare providers. The company was formerly known as Watson Pharmaceuticals, Inc. and changed its name to Actavis, Inc. in January 2013. Actavis, Inc. was founded in 1983 and is headquartered in Parsippany, New Jersey.
=================
阿特维斯公司,一个综合性的专业制药公司,从事开发,制造,营销,销售及分销通用的,通用的品牌,品牌,生物仿制药和非处方医药产品全球。该公司提供其产品的各种治疗类别,如心血管,皮肤科,泌尿科,womenÂ的健康,肿瘤,预防妊娠,激素和合成代用品,抗感染药,中枢神经系统,疼痛管理,抑郁症,高血压,注意力缺陷/多动障碍和戒烟。它通过三个分部:阿特维斯制药,阿特维斯特色品牌,安达分布。阿特维斯制药分部开发,生产和销售仿制药产品,以及分销通用版本的第三个partiesÂ'品牌产品。此分部提供各种剂型,如口服固体制剂,半固体,液体,凝胶,transdermals,注射,吸入,口服transmucosals。阿特维斯特色品牌分部促进和共同促进GELNIQUE Rapaflo,CRINONE,TRELSTAR,铁Generess,Androderm,Kadian,CRINONE,AndroGel,INFeD,葡萄糖酸铁钠品牌产品;和市场销售的专业人才,以及销售其产品通过各种非促进的产品。安达分销分部独立药房,替代保健提供者,连锁药店,和physiciansÂ办公室分配通用和选定的品牌医药产品,疫苗,注射剂,和过度的非处方药。阿特维斯公司,销售其仿制品牌医药产品主要药物批发商,零售商,分销商,医院,诊所,邮购,和政府机构,以及管理的医疗服务提供者。该公司的前身为沃森制药公司和阿特维斯公司在2013年1月更名为。 Actavis公司,公司成立于1983年,总部设在新泽西州Parsippany。
=================
|
|